Back
Arcutis Biotherapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.14
Seasonality Move:
-24.31%
Sell
47
MDGL
Madrigal Pharmaceuticals
Last Price:
242.38
Seasonality Move:
23.49%
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.39. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $233.33. The Score for MDGL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- MDGL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.39
The current trend is moderately bearish and ARQT is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $233.33
The current trend is relatively stagnant and MDGL is experiencing slight selling pressure.
ARQT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 53.01 | Buy |
Chaikin Money Flow: | 469104 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.08 - 10.94) | Buy |
Bollinger Bands (100): | (8.33 - 10.29) | Buy |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.37 | Sell |
Relative Strength Index (14 RSI): | 39.26 | Sell |
Chaikin Money Flow: | -56242 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (236.75 - 253.29) | Sell |
Bollinger Bands (100): | (225.94 - 277.64) | Sell |
ARQT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.53 | Sell |
20-day SMA: | 10.33 | Buy |
50-day SMA: | 9.91 | Buy |
200-day SMA: | 8.15 | Buy |
8-day EMA: | 10.45 | Sell |
20-day EMA: | 10.28 | Buy |
50-day EMA: | 9.91 | Buy |
200-day EMA: | 8.95 | Buy |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 235.51 | Sell |
20-day SMA: | 243.56 | Sell |
50-day SMA: | 258.23 | Sell |
200-day SMA: | 242.61 | Sell |
8-day EMA: | 236.38 | Sell |
20-day EMA: | 242.2 | Sell |
50-day EMA: | 250.62 | Sell |
200-day EMA: | 239.83 | Sell |
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.42 per share, an increase next quarter of $3.05 per share, a decrease this year of $9.33 per share, and an increase next year of $10.92 per share.
Arcutis Biotherapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |